Альманах клинической медицины. 2014; 1: 83-87
СИСТЕМА ГИСТОСОВМЕСТИМОСТИ ПРИ ТРАНСПЛАНТАЦИИ ПОЧКИ
https://doi.org/10.18786/2072-0505-2014-31-83-87Аннотация
Изложено современное представление об организации генов главного комплекса гистосовместимости, их белковых продуктах и номенклатуре лейкоцитарных антигенов человека.
Список литературы
1. Thorsby E. A short history of HLA. Tissue Antigens 2009;74(2): 101-16.
2. Шумаков В.И., ред. Трансплантология. Руководство. М.: Медицина – Тула: Репроникс Лтд; 1995. [Shumakov V.I., editor. Transplantology. Manual. Moscow: Meditsina – Tula: Reproniks Ltd; 1995 (in Russian)].
3. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000;343(10):702-9.
4. Marsh S.G., Albert E.D., Bodmer W.F., Bont rop R.E., Dupont B., Erlich H.A., Fernández-Viña M., Geraghty D.E., Holdsworth R., Hurley C.K., Lau M., Lee K.W., Mach B., Maiers M., Mayr W.R., Müller C.R., Parham P., Petersdorf E.W., Sasazuki T., Strominger J.L., Svejgaard A., Terasaki P.I., Tiercy J.M., Trowsdale J. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010;75(4):291-455.
5. Данович Г.М. Трансплантация почки. Пер. с англ. М.: ГЭОТАР-Медиа; 2013. [Danovich G.M. Renal transplantology. Moscow: GEOTAR-Media; 2013 (in Russian)].
6. Erlich H. HLA DNA typing: past, present, and future. Tissue Antigens 2012;80(1):1-11.
7. McCluskey J., Kanaan C., Diviney M. Nomenclature and serology of HLA class I and class II alleles. Curr Protoc Immunol 2003; Appendix 1:Appendix 1S.
8. Pabón M.A., Navarro C.E., Martin R., Rodríguez M., Martin I., Gaitán L., Gómez A., Lozano E. Minor histocompatibility antigens as risk factor for poor prognosis in kidney transplantation. Transplant Proc 2011;43(9):3319-23.
Almanac of Clinical Medicine. 2014; 1: 83-87
HISTOCOMPATIBILITY SYSTEM IN RENAL TRANSPLANTATION
https://doi.org/10.18786/2072-0505-2014-31-83-87Abstract
The paper presents a contemporary view on organization of genes in the major histocompatibility complex, their protein products, and nomenclature of human leukocyte antigens.
References
1. Thorsby E. A short history of HLA. Tissue Antigens 2009;74(2): 101-16.
2. Shumakov V.I., red. Transplantologiya. Rukovodstvo. M.: Meditsina – Tula: Reproniks Ltd; 1995. [Shumakov V.I., editor. Transplantology. Manual. Moscow: Meditsina – Tula: Reproniks Ltd; 1995 (in Russian)].
3. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000;343(10):702-9.
4. Marsh S.G., Albert E.D., Bodmer W.F., Bont rop R.E., Dupont B., Erlich H.A., Fernández-Viña M., Geraghty D.E., Holdsworth R., Hurley C.K., Lau M., Lee K.W., Mach B., Maiers M., Mayr W.R., Müller C.R., Parham P., Petersdorf E.W., Sasazuki T., Strominger J.L., Svejgaard A., Terasaki P.I., Tiercy J.M., Trowsdale J. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010;75(4):291-455.
5. Danovich G.M. Transplantatsiya pochki. Per. s angl. M.: GEOTAR-Media; 2013. [Danovich G.M. Renal transplantology. Moscow: GEOTAR-Media; 2013 (in Russian)].
6. Erlich H. HLA DNA typing: past, present, and future. Tissue Antigens 2012;80(1):1-11.
7. McCluskey J., Kanaan C., Diviney M. Nomenclature and serology of HLA class I and class II alleles. Curr Protoc Immunol 2003; Appendix 1:Appendix 1S.
8. Pabón M.A., Navarro C.E., Martin R., Rodríguez M., Martin I., Gaitán L., Gómez A., Lozano E. Minor histocompatibility antigens as risk factor for poor prognosis in kidney transplantation. Transplant Proc 2011;43(9):3319-23.
